Merck Serono
To Merck Serono next, and the Germany-headquartered company amongst a number of new appointments has announced Belén Garijo (left) is the new President and CEO.
Garijo joined the company in 2011 and previously served as COO. She also served as Senior Vice President, Global Operations Region Europe at Sanofi from 2006.
Stefan Oschmann (right) - who has been a Member of the Executive Board of Merck since January 2011 - has taken on the role of Head of Pharmaceuticals in charge of Merck Serono, Consumer Health, Allergopharma and Biosimilars.
He has previously served as President of Emerging Markets for the other Merck, known as MSD outside North America.
In other appointments, Dr. Annalisa Jenkins has been named Executive Vice President, Head of Global Research and Development, and Thierry Hulot is the new Senior Vice President, Head of the Biosimilars unit for Merck Serono and designated Head of Global Manufacturing & Supply, as of October 1